M4Eo

acute myelomonocytic leukemia with abnormal eosinophils.

References in periodicals archive ?

51,69) Unlike AML M4Eo, where granules are enlarged, the granules in chronic eosinophilic leukemia associated with FIP1L1-PDGFRA are commonly small and sparse (Figure 2, A and B).

Diagnostic complexities of eosinophilia

Schnittger S, Bacher U, Haterlach C, Kern W and Haferlach T, Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients Leukemia 2007;21:725-31.

The importance of protein profiling in the diagnosis and treatment of hematologic malignancies / Hematolojik malignitelerin tani ve tedavisinde protein profillemenin onemi

Two patients had AL (one type B, common; and one biphenotypic), and 105 had acute myeloid leukemia: 1 with French-American-British subtype Mo, 11 with subtype M1, 13 with subtype M2, 65 with subtype M3, 4 with subtype M4, 2 with subtype M4Eo, 5 with subtype M5, 2 with subtype M6, 1 who was not classified, and 1 with subtype M1 at relapse.

Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies

Patients with t(8; 21) frequently present with the French-American-British (FAB) morphologic subtype M2 or acute myeloid leukemia with differentiation, while patients with inv(16) more often are diagnosed with FAB subtype M4Eo or acute myelomonocytic leukemia with eosinophilia.

Core-binding factor acute myeloid leukemia

Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.

Significance of molecular-cytogenetic aberrations for the achievement of first remission in de novo acute myeloid leukemia/Dogustan olmayan akut miyeloid losemiye yonelik ilk gerilemenin kazanilmasinda molekuler sitogenetik aberasyonlarin onemi

Clinical aspects of acute myeloid leukemias of the Fab types M3 and M4Eo.

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions